Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AngioSafe, Inc. logo — Developing a pipeline of novel devices to improve safety and...

AngioSafe, Inc.

Developing a pipeline of novel devices to improve safety and efficacy of complex cardiovascular interventions.

Founded 2014 United States San Jose, United States 18 employees

General Information

Company Name AngioSafe, Inc.
Founded Year 2014
Location United States San Jose, United States +1
Employees 18
Social

Get notified when AngioSafe, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AngioSafe, Inc.

AngioSafe, Inc. is a pre-commercial stage company with a clear focus on developing novel devices to address the challenges of complexity, safety, and efficacy in cardiovascular interventions for peripheral and coronary artery disease. Since its establishment in 2014, the company has been dedicated to improving the safety and effectiveness of complex cardiovascular procedures, reflecting its slogan, "Developing a pipeline of novel devices to improve safety and efficacy of complex cardiovascular interventions." Based in the United States, AngioSafe is strategically positioned in a key market for cardiovascular innovations. With its innovative pipeline of devices, the company presents an attractive opportunity for potential investors and demonstrates significant potential for growth and impact within the cardiovascular healthcare sector. As AngioSafe moves towards commercialization, it represents a compelling investment prospect within the medical device industry for venture capitalists seeking promising opportunities with the potential for substantial returns.

Taxonomy: Cardiovascular Interventions, Clinical Development, Peripheral Artery Disease, Coronary Artery Disease, Catheters, Safety, Efficacy, Design Engineering, Test Engineering, Quality Control, Critical Limb Ischemia, Preclinical Development, Commercialization

No funding data available for AngioSafe, Inc. yet.

Get notified when AngioSafe, Inc. raises funding

AngioSafe, Inc. Alternatives & Competitors

AngioSafe, Inc. vs
HEART & VASCULAR CARE CONSULTANTS, LLC
HEART & VASCULAR CARE CONSULTANTS, LLC

Every heartbeat matters, with precise diagnostics and compassionate care.

30 employees
Health Care, Health and Wellness
AngioSafe, Inc. vs
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. United States

Cardiovascular Systems, Inc. (CSI) is committed to providing innovative solutions for the revascular...

Post Ipo Debt
343 employees
Biotechnology, Health Care
AngioSafe, Inc. vs
Miami Vascular Surgery
Miami Vascular Surgery United States

Leading providers of vascular health.

13 employees
Health Care

FAQ About AngioSafe, Inc.

Developing a pipeline of novel devices to improve safety and efficacy of complex cardiovascular interventions.
AngioSafe, Inc. was founded in 2014.
AngioSafe, Inc. is headquartered in San Jose, United States.
AngioSafe, Inc. has approximately 18 employees.
Top alternatives and competitors to AngioSafe, Inc. include HEART & VASCULAR CARE CONSULTANTS, LLC, Cardiovascular Systems, Inc., Miami Vascular Surgery, Soundbite Medical Solutions Inc., Morris Heart Assoc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AngioSafe, Inc. and HEART & VASCULAR CARE CONSULTANTS, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AngioSafe, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy